Get SCDM CCDM Exam Practice Questions - Real and Updated

Answer : D

The Investigator holds the primary responsibility for ensuring the accuracy, completeness, and timeliness of Case Report Form (CRF) entries. This responsibility is mandated by regulatory requirements under ICH E6(R2) Good Clinical Practice (GCP).

The investigator may delegate CRF completion to a qualified designee (e.g., site coordinator), but the ultimate accountability remains with the investigator. The investigator's signature (electronic or manual) on the CRF serves as certification that the data accurately reflect the source documents and the patient's participation.

The GCDMP (Chapter: CRF Design and Data Collection) reinforces this by stating that while data managers ensure design quality and CRAs verify consistency with source data, the investigator is legally responsible for CRF accuracy.

Thus, option D (Investigator) is correct, as it aligns with both GCP and CCDM standards.

Reference (CCDM-Verified Sources):

ICH E6(R2) GCP, Section 4.9 -- Records and Reports (Investigator Responsibilities)

SCDM GCDMP, Chapter: CRF Design and Data Collection, Section 5.1 -- Investigator's Role in Data Accuracy

FDA 21 CFR Part 312.62 -- Investigator Recordkeeping and Record Retention

Answer : B

When a system validation test fails during Electronic Patient-Reported Outcome (ePRO) system testing, the validation documentation must record the expected results (what should have occurred) and the actual results (what occurred).

According to the GCDMP (Chapter: Database Validation and Testing), proper system validation documentation ensures traceability, reproducibility, and compliance with FDA 21 CFR Part 11 and ICH E6 (R2). Each test case must include:

Test objective,

Preconditions,

Test steps,

Expected results,

Actual results, and

Pass/fail status.

If a test fails, this documentation provides the objective evidence necessary for deviation handling, issue resolution, and re-testing. While a separate root cause analysis may be performed later (option D), the validation record itself must focus on verifying outcomes against predefined expectations.

Therefore, the correct answer is B -- Expected and actual results.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Validation and Testing, Section 4.4 -- Documentation of Test Results

FDA 21 CFR Part 11 -- Validation Requirements (Section 11.10(a))

ICH E6 (R2) GCP, Section 5.5.3 -- Computer System Validation and Documentation

Answer : B

In a relational database system used in clinical data management, performance refers to how efficiently the system processes transactions, retrieves data, and handles large volumes of information without delay or data integrity issues. Among the listed options, loading a large lab data file into the database (Option B) has the most significant impact on database performance.

According to the Good Clinical Data Management Practices (GCDMP, Chapter on Database Design and Build), the bulk data load process --- such as importing large external datasets (e.g., central lab data, ECG results, or imaging metadata) --- can be computationally intensive. This process engages the database's input/output (I/O) subsystem, indexing mechanisms, and transaction logs simultaneously, often locking tables temporarily and consuming significant memory and processing resources.

Unlike standard CRF data entry (Option A) or record updates (Option D), which are incremental and typically processed in smaller transactional batches, bulk loading operations handle thousands or millions of rows at once. If not optimized (e.g., via staging tables, indexing strategies, or commit frequency control), such operations can degrade system performance, slow down concurrent user access, and increase the risk of transaction failure.

Executing a properly designed query (Option C) can also be resource-intensive depending on data volume and join complexity, but when queries are properly optimized (using indexed keys, efficient SQL joins, and selective retrieval), their impact is generally controlled and transient compared to large data imports.

Therefore, as outlined in the GCDMP Database Design and Build and FDA Computerized Systems Guidance, the most performance-impacting activity in a relational database is bulk loading large external datasets, making Option B the correct answer.

Reference (CCDM-Verified Sources):

Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: Database Design and Build, Section 6.7 -- Database Performance and Optimization

FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6 -- System Performance and Data Handling Efficiency

ICH E6 (R2) Good Clinical Practice, Section 5.5 -- Data Handling and Record Integrity

CDISC Operational Data Model (ODM) Implementation Guide -- Bulk Data Transfer and Validation Considerations

Answer : D

The most effective method for quality control (QC) of the query resolution process is to perform random audits of resolved query forms. This ensures that queries are being appropriately raised, addressed, and resolved in accordance with the study protocol, data management plan (DMP), and standard operating procedures (SOPs).

According to the GCDMP (Chapter: Data Validation and Cleaning), QC activities should verify that the data review and query management process maintains high accuracy and consistency. Random auditing of resolved queries enables verification that:

Queries were raised for legitimate discrepancies,

The site's responses were appropriate, and

The resolution actions taken by data management were correct and well-documented.

Metrics such as turnaround time (options A and C) or query counts (option B) measure efficiency but do not assess quality. True quality control focuses on ensuring that data corrections preserve accuracy, auditability, and traceability --- the fundamental principles of data integrity in clinical research.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 5.4 -- Query Management and Quality Control

ICH E6 (R2) GCP, Section 5.5.3 -- Data Integrity and Validation Procedures

Answer : A

The primary reason a statistician reviews the Case Report Form (CRF) is to ensure that the data being collected will support the planned statistical analyses for both safety and efficacy endpoints.

According to the Good Clinical Data Management Practices (GCDMP, Chapter: CRF Design and Data Collection), CRF design should always align with the statistical analysis plan (SAP) to ensure that all necessary data elements are collected accurately and in analyzable formats. The statistician verifies that the CRF captures:

All endpoints specified in the protocol

Proper derivation or calculation fields

Timing of assessments

Consistency across visits and forms

Options B, C, and D address secondary or technical design considerations but not the primary analytical purpose. The review ensures that the CRF provides a complete and analyzable dataset for meeting study objectives, regulatory submissions, and statistical integrity.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: CRF Design and Data Collection, Section 4.4 -- Role of Statistics in CRF Design

ICH E9 -- Statistical Principles for Clinical Trials, Section 5.2 -- Data Collection and Analysis Alignment

FDA Guidance for Industry: E6(R2) GCP, Section 5.1 -- Quality Management and Design Input from Stakeholders